Literature DB >> 2180580

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.

H Ohno1, G Takimoto, T W McKeithan.   

Abstract

A gene, bcl-3, is found on chromosome 19 adjacent to the breakpoints in the translocation t(14;19)(q32;q13.1), which occurs in some cases of chronic lymphocytic leukemia. Sequence analysis of the human bcl-3 gene predicts a protein containing seven tandem copies of the SWI6/cdc10 motif. This motif was previously identified in yeast genes that regulate events at the start of the cell cycle and in invertebrate transmembrane proteins involved in cell differentiation pathways. Expression of bcl-3 in normal blood cells increases markedly following mitogenic stimulation, and leukemic cells with the translocation show much greater expression than controls. These results suggest that bcl-3 is a proto-oncogene that may contribute to leukemogenesis when abnormally expressed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180580     DOI: 10.1016/0092-8674(90)90347-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  133 in total

Review 1.  Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.

Authors:  R T Hay; L Vuillard; J M Desterro; M S Rodriguez
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Characterization of Chlamydomonas reinhardtii zygote-specific cDNAs that encode novel proteins containing ankyrin repeats and WW domains.

Authors:  H Kuriyama; H Takano; L Suzuki; H Uchida; S Kawano; H Kuroiwa; T Kuroiwa
Journal:  Plant Physiol       Date:  1999-03       Impact factor: 8.340

3.  Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

Authors:  F Michel; M Soler-Lopez; C Petosa; P Cramer; U Siebenlist; C W Müller
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

4.  Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.

Authors:  T T Huang; S Miyamoto
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription.

Authors:  D C Hay; G D Kemp; C Dargemont; R T Hay
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.

Authors:  Wanhu Tang; Hongshan Wang; Estefania Claudio; Ilaria Tassi; Hye-lin Ha; Sun Saret; Ulrich Siebenlist
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

7.  The BCL3 locus on chromosome 19 displays an informative microsatellite polymorphism.

Authors:  P H St George-Hyslop; H Ohno; J F Gusella; T McKeithan
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

8.  The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

Authors:  Aurore Keutgens; Kateryna Shostak; Pierre Close; Xin Zhang; Benoît Hennuy; Marie Aussems; Jean-Paul Chapelle; Patrick Viatour; André Gothot; Marianne Fillet; Alain Chariot
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

9.  Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.

Authors:  M A Christine Pratt; Tanya E Bishop; Dawn White; Gordon Yasvinski; Michel Ménard; Min Ying Niu; Robert Clarke
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors.

Authors:  E Garoufalis; I Kwan; R Lin; A Mustafa; N Pepin; A Roulston; J Lacoste; J Hiscott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.